Wellesley, MA, United States of America

Raul San Jose Estepar

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Raul San Jose Estepar

Introduction

Raul San Jose Estepar is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of medical imaging and cancer risk prediction. With a total of 3 patents, his work focuses on developing advanced systems for predicting lung cancer risk.

Latest Patents

Raul's latest patents include innovative systems and methods for predicting the risk of future lung cancer. These risk prediction models are trained and deployed to analyze images, such as computed tomography scans, to assess the risk of lung cancer for one or more subjects. Individual risk prediction models are trained on both nodule-specific and non-nodule specific features, allowing for accurate predictions across different time horizons. This technology is instrumental in developing preventive therapies for lung cancer by enabling clinical trial enrichment.

Career Highlights

Raul San Jose Estepar is currently associated with Johnson & Johnson Enterprise Innovation Inc., where he continues to push the boundaries of medical technology. His work has garnered attention for its potential to improve patient outcomes through early detection and risk assessment.

Collaborations

Some of Raul's notable coworkers include George R Washko and Christopher Scott Stevenson. Their collaborative efforts contribute to the innovative environment at Johnson & Johnson Enterprise Innovation Inc.

Conclusion

Raul San Jose Estepar's contributions to lung cancer risk prediction exemplify the impact of innovation in healthcare. His patents reflect a commitment to advancing medical technology for better patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…